review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0889-8588(18)30508-2 |
P698 | PubMed publication ID | 2107173 |
P2093 | author name string | Miller JL | |
P2860 | cites work | Inducible secretion of large, biologically potent von Willebrand factor multimers | Q24296142 |
Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells | Q24301929 | ||
Amino acid sequence of human von Willebrand factor | Q28630812 | ||
IIB von Willebrand's disease: pathogenetic and therapeutic studies | Q33447346 | ||
Investigation of a large kindred with type IIB von Willebrand's disease, dominant inheritance and age-dependent thrombocytopenia | Q33449113 | ||
Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease | Q33478045 | ||
von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease | Q33478102 | ||
Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent | Q33481601 | ||
Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers | Q33481677 | ||
Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura | Q33481821 | ||
Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease | Q33567446 | ||
Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation | Q34521638 | ||
Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). | Q34528381 | ||
von Willebrand protein facilitates platelet incorporation in polymerizing fibrin | Q34544068 | ||
von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia | Q34574601 | ||
Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation | Q34624945 | ||
Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases | Q70432905 | ||
Von Willebrand factor multimer patterns in von Willebrand's disease | Q70454272 | ||
Platelet aggregation induced by DDAVP in platelet-type von Willebrand's disease | Q71003140 | ||
Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease | Q71498185 | ||
Studies on the pathophysiology and treatment of von Willebrand's disease. IV. Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand's disease | Q71535514 | ||
Pathogenesis of antibody-induced acquired von Willebrand Syndrome | Q71540345 | ||
Factor VIII and human platelet aggregation. III. Further studies on aggregation of humna platelets by neuraminidase-treated human factor VIII | Q95790452 | ||
The interaction of bovine factor VIII with human platelets | Q35195700 | ||
Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene | Q35811246 | ||
Cloning and characterization of two cDNAs coding for human von Willebrand factor. | Q36413864 | ||
Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method | Q36487544 | ||
Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene. | Q36487665 | ||
Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets | Q36983829 | ||
Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand's disease (type IIC) | Q36988093 | ||
An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor | Q36994972 | ||
Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets | Q37023086 | ||
Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin | Q37034062 | ||
Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease | Q37046074 | ||
Synthesis of Factor VIII Antigen by Cultured Guinea Pig Megakaryocytes | Q37047673 | ||
Synthesis of von Willebrand factor by cultured human endothelial cells | Q37444356 | ||
Factor-VIII-related antigen: multiple molecular forms in human plasma | Q37466525 | ||
In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease | Q37531782 | ||
Role of von Willebrand factor in the vessel wall | Q39168456 | ||
A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIII. Recovery after splenectomy | Q39641337 | ||
Nucleotide sequence of pre-pro-von Willebrand factor cDNA. | Q40418506 | ||
von Willebrand's disease and hemorrhagic telangiectasia: association of two complex disorders of hemostasis resulting in life-threatening hemorrhage | Q40642696 | ||
Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder | Q40674913 | ||
Telangiectasia and von Willebrand's Disease in Two Families | Q40694936 | ||
Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: New stable platelet preparations for von Willebrand factor assays | Q40705105 | ||
Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia | Q40725036 | ||
The Factor VIII Abnormality in Severe von Willebrand's Disease | Q40726737 | ||
Gene deletions correlate with the development of alloantibodies in von Willebrand disease | Q40922128 | ||
An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope. | Q44363513 | ||
Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease | Q45863842 | ||
Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test | Q45878186 | ||
DDAVP in acquired von Willebrand syndrome associated with multiple myeloma | Q45886916 | ||
Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor | Q45887412 | ||
Multimeric analysis of von Willebrand factor in megakaryocytes | Q46859910 | ||
Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization | Q48377892 | ||
Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II | Q56459904 | ||
Adenosine diphosphate induces binding of von Willebrand factor to human platelets | Q59095973 | ||
Plasma and platelet von Willebrand factor defects in uremia | Q68100239 | ||
Multimeric composition of plasma von Willebrand factor in chronic myelocytic leukaemia | Q68100612 | ||
A monoclonal antibody based immunoradiometric assay for von Willebrand factor: survey of a large patient group | Q68817994 | ||
Essential thrombocythemia with acquired von Willebrand's disease | Q68824037 | ||
Successful treatment of an acquired von Willebrand factor antibody by extracorporeal immunoadsorption | Q69482394 | ||
Hemostatic evaluation in bleeding disorders from native blood. Clinical experience with the hemostatometer | Q69488535 | ||
Botrocetin- and polybrene-induced platelet aggregation in platelet-type von Willebrand disease | Q69864886 | ||
A comparative study of variables affecting the bleeding time using two disposable devices | Q69935411 | ||
von Willebrand disease | Q70321843 | ||
P433 | issue | 1 | |
P304 | page(s) | 107-128 | |
P577 | publication date | 1990-02-01 | |
P1433 | published in | Hematology / Oncology Clinics of North America | Q15749192 |
P1476 | title | von Willebrand disease | |
P478 | volume | 4 |
Q72896911 | Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and L-thyroxine therapy |
Q37346455 | Laboratory diagnosis of von Willebrand's disease |
Q45099698 | Management of children with von Willebrand disease undergoing adenotonsillectomy |
Q45090528 | Prevalence of von Willebrand disease in children: a multiethnic study |
Q40997967 | von Willebrand disease in children and adolescents |
Search more.